1. All Products
  2. MIDAZOLAM, 5mg/ml, 10ml, amp
Public Pricelist

MIDAZOLAM, 5mg/ml, 10ml, amp

https://unicat.msf.org/cat/product/76935
STD DINJMIDA50A

Valid Article

The product is supplied (and stored) sterile, it must remain sterile until its use. Sterile = state of being free from all living microorganisms.
2.3 - Medicines for other common symptoms in palliative care
Classification of the medicines in groups and subgroups according to their therapeutic use. The classification used by MSF is based on the WHO Model List of Essential Medicines.
N05CD08
Anatomical Therapeutic Chemical Classification according to WHOCC
A
The order of this product needs to be justified and is only acceptable under certain conditions.
P4
Substance listed as Narcotic Drug or Psychotropic Substance, and as precursors. Other substances may be subject to restrictions according to national regulations. These substances require an import permit from the country of destination when ordering.
1525
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
OC subscriptions: included in supply or field order tools (e.g. UniField)
SC subscriptions: included in supply or field tools
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
https://unicat.msf.org/web/image/product.template/577678/image_1920?unique=e0ad638

This combination does not exist.

Add article to list

   
Create Cancel

Add Kit To Wishlist

   
Create Cancel

MIDAZOLAM, 5mg/ml, amp

Therapeutic Action

Short-acting hypnotic and sedative with anxiolytic, anticonvulsant and muscle relaxant effect.

Derivative of the benzodiazepine group

Indications

Sedation of adult and paediatric patients in intensive care units, in combination with other anaesthetic agents, administered as a continuous IV infusion.

Some restricted information has been hidden. Sign in to see this information

Instructions for use

Must be given as continuous IV infusion in critical care settings.

Midazolam should only be administered by personnel specifically trained in the detection and management of airway obstruction, hypoventilation and apnoea, including maintenance of cardiopulmonary function, and with experience in cardiovascular resuscitation.

A benzodiazepine reversal agent (flumazenil DINJFLUM1A) should be immediately available during the administration of midazolam.

Systematically order the corresponding pre-printed label to identify the syringe containing the product (see related articles)

Distribution to be controlled: narcotics register or supervision of amounts in and out, and storage under lock and key. (Cf Introduction: Narcotic and psychotropic medicines under international control).

Precautions for Use

Caution! This concentration (5mg/ml) is reserved for continuous IV infusion in intensive care units.

Storage

  • Below 25ºC - Protect from sunlight
  • After opening the ampoule, use the product immediately.